PRELIMINARY RESULTS OF PEDIATRIC LIVER TRANSPLANTATION AT UNIVERSITY MEDICAL CENTER HO CHI MINH CITY

Công Duy Long Trần 1,2, , Phước Nghĩa Phan 1, Thị Thanh Thủy Trần 1
1 University Medical Center Ho Chi Minh City
2 University of Medicine and Pharmacy at Ho Chi Minh City

Main Article Content

Abstract

Objective: Pediatric liver transplantation (LT) is the definitive life-saving treatment for children with end-stage liver disease or irreversible liver failure. This study reports the initial outcomes of the pediatric liver transplantation program established at University Medical Center (UMC) Ho Chi Minh City.


Patients and Methods: We conducted a retrospective cohort study of pediatric patients (< 16 years old) who underwent LT between December 2021 and April 2026 at University Medical Center, Ho Chi Minh City. Data on recipient and donor characteristics, operative variables, postoperative complications, and survival rates were collected and analyzed.


Results: Forty-four cases were included with a median follow-up of 17.97 months (IQR: 6.83 – 36.93; range: 0.26 – 93.69). The median age was 2 years and median weight was 10 kg; biliary atresia was the primary indication (81.8%). Living donor liver transplantation (LDLT) accounted for 88.6% of cases, with 66.7% of donor hepatectomies performed laparoscopically. The median graft-to-recipient weight ratio (GRWR) was 2.28. Median operative time was 590 minutes, and blood loss was 655 mL. Common complications included pleural effusion requiring drainage (22.7%), acute rejection (18.2%), and CMV infection (9.1%). Cumulative 1-year and 3-year survival rates were 90.5% (95% CI: 76.7 – 96.3%).


Conclusion: Early implementation of pediatric LT at our center is feasible and demonstrates encouraging survival outcomes. While surgical complications remain low, optimizing perioperative care for respiratory and infectious challenges is essential.

Article Details

References

1. Kasahara M, Umeshita K, Eguchi S, et al. Outcomes of Pediatric Liver Transplantation in Japan: A Report from the Registry of the Japanese Liver Transplantation Society. Transplantation. 2021 Dec 1;105(12):2587-2595.
2. Kwong AJ, Ebel NH, Kim WR, et al. OPTN/SRTR 2021 Annual Data Report: Liver. Am J Transplant. 2023 Feb;23(2 Suppl 1):S178-S263.
3. Phạm Duy Hiền, Nguyễn Phạm Anh Khoa, Vũ Mạnh Hoàng và cs. Kết quả ghép gan từ người hiến sống điều trị teo mật bẩm sinh ở trẻ em tại Bệnh viện Nhi Trung Ương. Tạp chí Y học Việt Nam 2023;527(2):15-20.
4. Trần Thanh Trí, Hồ Phi Duy, Nguyễn Hồng Vân Khánh và cs. Ghép tạng tại Bệnh viện Nhi Đồng 2: những thành tựu và thách thức. Tạp chí Y học Việt Nam 2023;530(1):263-268.
5. Tran TT, Ho PD, Luu NAT, et al. Implementing living-donor pediatric liver transplantation in Southern Vietnam: 15-year results and perspectives. Pediatr Transplant. 2024 Feb;28(1):e14441.
6. Barbetta A, Butler C, Barhouma S, et al. Living Donor Versus Deceased Donor Pediatric Liver Transplantation: A Systematic Review and Meta-analysis. Transplant Direct. 2021 Sep 20;7(10):e767.
7. Kim WJ, Kim KH, Cho HD, et al. Long-Term Safety and Efficacy of Pure Laparoscopic Donor Hepatectomy in Pediatric Living Donor Liver Transplantation. Liver Transpl. 2021 Apr;27(4):513-524.
8. Knackstedt ED, Anderson SG, Anand R, et al. Society of Pediatric Liver Transplantation. Cytomegalovirus prophylaxis in pediatric liver transplantation: A comparison of strategies across the Society of Pediatric Liver Transplantation (SPLIT) consortium. Am J Transplant. 2025 May;25(5):1098-1106.